Pyxis Oncology, Inc. (PYXS) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -26M | -10.43M | -13.28M | -17.26M | -22.54M | -19.29M | -14.66M | -3.01M | -20.71M | -15.25M | -17.58M | -11.03M | -26.84M | -17.39M | -20.56M | -23.71M | -27.68M | -12.17M | -7.29M | 2.86M |
| Operating CF Margin % | - | -94.46% | - | -612.16% | - | - | - | - | -128.27% | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -15.38% | 45.95% | 9.46% | -474.09% | -8.81% | -26.46% | 16.6% | 72.74% | 22.84% | 12.27% | 14.47% | 53.48% | 3.03% | -42.88% | -182.07% | -928.51% | -47.77% | -284.24% | - | - |
| Net Income | -23.27M | -18.11M | -22M | -18.35M | -21.16M | -35.57M | -21.2M | -17.3M | -3.26M | -15.6M | -23.05M | -15.9M | -19.24M | -36.1M | -27.67M | -25.56M | -31.38M | -16.83M | -14.18M | -8.15M |
| Depreciation & Amortization | 459K | 2.9M | 527K | 535K | 552K | 550K | 731K | 585K | 1.12M | 690K | 523K | 524K | 190K | 192K | 200K | 159K | 158K | 158K | 159K | 217K |
| Stock-Based Compensation | 0 | 2.08M | 3.07M | 3.02M | 3.63M | 2.77M | 2.98M | 2.87M | 4.32M | 3.21M | 5.18M | 3.67M | 4.88M | 3.9M | 4.45M | 4.01M | 3.4M | 3.11M | 307K | 572K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.2M | -156K | -322K | -694K | -964K | 19.62M | -1.47M | -1.47M | -1.12M | -1.25M | -1.33M | 175K | -463K | 9.55M | 307K | 316K | 232K | 566K | 2.71M | 2.29M |
| Working Capital Changes | -4.39M | 2.86M | 5.45M | -1.76M | -4.6M | -6.66M | 4.3M | 12.3M | -21.77M | -2.31M | 1.09M | 1.76M | -12.21M | 5.07M | 2.16M | -2.64M | -93K | 824K | 3.71M | 7.93M |
| Change in Receivables | 0 | 0 | 0 | -3M | 0 | 0 | 0 | 8M | -8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -5.9M | 1.13M | 344K | 6.57M | -2.01M | -10K | -602K | 3.18M | -1.36M | 350K | -1.54M | -1.56M | -753K | -1.89M | -2.31M | 5.76M | -9.9M | 4.03M | 974K | 83K |
| Cash from Investing | 16.37M | 16.26M | 11.47M | 15.3M | 15.82M | 26.66M | -8K | 4K | -18.5M | 10.23M | 6.57M | -22.25M | -99.39M | -1.86M | -4.27M | -129K | -146K | 0 | 0 | -371K |
| Capital Expenditures | 0 | 0 | -9K | 0 | 0 | 0 | 0 | 0 | -237K | 0 | -61K | -2.26M | -4.41M | -1.86M | -4.27M | -129K | -146K | 0 | 0 | -371K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | 1.47% | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 0 | -15.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -107.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.66M | 15.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -25K | 669K | -8K | -67K | 0 | 50K | 1.66M | 110K | 57.51M | -25K | -171K | 6.13M | 0 | 0 | 6K | 1K | 176K | 154.9M | -1.71M | -682K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 740K | 0 | -67K | 2K | 0 | 1.48M | 105K | 57.46M | 0 | 0 | 6.12M | 0 | 0 | 0 | 0 | 0 | 152.3M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -25K | -71K | -8K | 0 | -2K | 50K | 176K | 5K | 49K | -25K | -171K | 3K | 0 | 0 | 6K | 1K | 176K | 2.6M | -1.71M | -682K |
| Net Change in Cash | -9.66M | 6.5M | -1.81M | -2.03M | -6.71M | 7.42M | -13.02M | -2.89M | 18.3M | -5.05M | -11.18M | -27.16M | -126.23M | -19.25M | -24.82M | -23.84M | -27.65M | 142.73M | -8.99M | 1.81M |
| Free Cash Flow | -26M | -10.43M | -13.29M | -17.26M | -22.54M | -19.29M | -14.66M | -3.01M | -20.95M | -15.25M | -17.64M | -13.29M | -31.25M | -19.25M | -24.82M | -23.84M | -27.82M | -12.17M | -7.29M | 2.49M |
| FCF Margin % | - | -94.46% | - | -612.16% | - | - | - | - | -129.73% | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -15.38% | 45.95% | 9.4% | -474.09% | -7.58% | -26.46% | 16.88% | 77.37% | 32.96% | 20.74% | 28.92% | 44.26% | -12.3% | -58.15% | -240.6% | -1057.09% | -47.22% | -284.24% | - | - |
| FCF per Share | -0.41 | -0.17 | -0.21 | -0.28 | -0.37 | -0.32 | -0.24 | -0.05 | -0.41 | -0.34 | -0.43 | -0.35 | -0.88 | -0.55 | -0.76 | -0.73 | -0.86 | -0.38 | -0.23 | 0.08 |
| FCF Conversion (FCF/Net Income) | 1.12x | 0.58x | 0.60x | 0.94x | 1.07x | 0.54x | 0.69x | 0.17x | 6.36x | 0.98x | 0.76x | 0.69x | 1.39x | 0.48x | 0.74x | 0.93x | 0.88x | 0.72x | 0.51x | -0.35x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28K | 20K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |